{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T21:17:35Z","timestamp":1771103855409,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2019,3,15]]},"DOI":"10.1007\/s00246-019-02072-9","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T05:46:39Z","timestamp":1550814399000},"page":"668-670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Levosimendan as Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy"],"prefix":"10.1007","volume":"40","author":[{"given":"Dorin","family":"Sumanaru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loic","family":"Josseran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aben","family":"Essid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blaise","family":"Mbieleu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Haegy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7673-4455","authenticated-orcid":false,"given":"Jean","family":"Bergounioux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"2072_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","volume":"26","author":"G Nigro","year":"1990","unstructured":"Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26:271\u2013277","journal-title":"Int J Cardiol"},{"key":"2072_CR2","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1161\/01.CIR.98.20.2141","volume":"98","author":"G Hasenfuss","year":"1998","unstructured":"Hasenfuss G, Pieske B, Castell M, Kretschmann B, Maier LS, Just H (1998) Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation 98:2141\u20132147","journal-title":"Circulation"},{"key":"2072_CR3","doi-asserted-by":"publisher","first-page":"532","DOI":"10.5603\/CJ.2011.0009","volume":"18","author":"S Lunghetti","year":"2011","unstructured":"Lunghetti S, Palmerini E, Urselli R et al (2011) Effects of levosimendan without loading dose on systolic and diastolic function in patients with end-stage heart failure. Cardiol J 18:532\u2013537","journal-title":"Cardiol J"},{"key":"2072_CR4","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s00134-005-2619-z","volume":"31","author":"A Morelli","year":"2005","unstructured":"Morelli A, De Castro S, Teboul JL et al (2005) Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31:638\u2013644","journal-title":"Intensive Care Med"},{"key":"2072_CR5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","volume":"360","author":"F Follath","year":"2002","unstructured":"Follath F, Cleland JG, Just H et al (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360:196\u2013202","journal-title":"Lancet"},{"issue":"12","key":"2072_CR6","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.amjcard.2006.07.043","volume":"98","author":"P Flevari","year":"2006","unstructured":"Flevari P, Parissis JT, Leftheriotis D, Panou F, Kourea K, Kremastinos DT (2006) Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy. Am J Cardiol 98(12):1641\u20131645","journal-title":"Am J Cardiol"},{"issue":"7","key":"2072_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2165\/00003088-200746070-00001","volume":"46","author":"S Antila","year":"2007","unstructured":"Antila S, Sundberg S, Lehtonen LA (2007) Clinical pharmacology of levosimendan. Clin Pharmacokinet 2007;46(7):535\u2013552 (Review)","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"2072_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/14017430410025783","volume":"38","author":"J Lilleberg","year":"2004","unstructured":"Lilleberg J, Yl\u00f6nen V, Lehtonen L, Toivonen L (2004) The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies. Scand Cardiovasc J 38(2):80\u201384","journal-title":"Scand Cardiovasc J"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-019-02072-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-019-02072-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-019-02072-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:13:48Z","timestamp":1744175628000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-019-02072-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3,15]]}},"alternative-id":["2072"],"URL":"https:\/\/doi.org\/10.1007\/s00246-019-02072-9","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]},"assertion":[{"value":"10 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors assert that all procedures contributing to this work comply with the ethical standard of the relevant national guidelines on human experimentation (1988 Huriet Law and 2004 Public Health Policy Law) and with the Helsinki Declaration of 1975, as revised in 2008, and has been approved by the institutional committee Comit\u00e9 de Protection des Personnes Ile-de-France XI, Saint-Germain en Lay, France.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}